Listen on the go
CORRECT!
Next question
touchHAEMATOLOGY touchHAEMATOLOGY

Start Learning

Touch Loading image
CONFERENCE HUB
Start Learning
Cevostamab in triple-class refractory RRMM: The CAMMA 2 Study
JOURNALS
Start Learning
Novel CD7-targeted CAR T-cell therapy elicits strong responses in relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma
JOURNALS
Start Learning
Supporting haematology patient care: Insights from the Haematology Nurses and Healthcare Professionals Group
Madrid
JOURNALS
Start Learning
EHA 2024: Highlights of the late-breaking abstracts
JOURNALS
Start Learning
Empowering young haematologists: Insights from the EBMT Trainee Committee co-chairs
touchFEATURE
Start Learning
Isatuximab demonstrated consistent PFS benefits across diverse patient profiles in RRMM in 2 pivotal trials
Sponsored content
CONFERENCE HUB
Start Learning
Durable clinical benefit with elritercept in lower-risk MDS: KER050-MD-201 trial
JOURNALS
Start Learning
#ASH24: Discover the 2024 late-breaking abstracts
CONFERENCE HUB
Start Learning
Is there an alternative to intensive chemotherapy for patients with acute myeloid leukemia? Key insights from ASH 2024
CONFERENCE HUB
Start Learning
Should we intensify chemotherapy in the treatment of acute myeloid leukemia? Insights from ASH 2024

to view Favourites, Keep Notes and Track CME Credits

Favourites
Emerging treatment strategies in GVHD
View
Cevostamab in triple-class refractory RRMM: The CAMMA 2 Study
View
Front-line ibrutinib-rituximab improves survival in mantle cell lymphoma
View
EHA 2024: Highlights of the late-breaking abstracts
View
Combination therapy in myelofibrosis: John Mascarenhas on the IMpactMF trial
View
Supporting young haematologists: Insights on YoungEHA and EHA 24
View
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
View
Looking to the future in the treatment of steroid-refractory chronic GvHD
View
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
View
Recognizing and managing HLH in the critical care setting: Best practice for the multidisciplinary team
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup